The role of SGLT2 inhibitors and GLP-1s in CKD
How combination therapy works to protect the kidneys while managing weight and blood sugar.
Written by Professor Mohammed Mahdi Althaf
Overview
Many patients are now prescribed both SGLT2 inhibitors (like Dapagliflozin) and GLP-1 agonists. This combination offers potent kidney protection but increases the need for careful monitoring of blood pressure and hydration.
This article is general information and is not individual medical advice. Treatment decisions are made at a face-to-face consultation.